# Study Protocol: Connecting older adults through multi-level programmes for alleviating loneliness in Hong Kong older adults (COMPASS-HOA)

**Authors:** Vivien Foong Yee Tang, Da Jiang, Jojo Yan Yan Kwok, Henry C. Y. Ho, Izzy Yi Jian, Namkee G. Choi, Tegan Cruwys, Joyce Hoi Sze You, Lisa M. Warner, Noëmi Seewer, Xue Bai, Anton Käll, Gerhard Andersson, Tobias Krieger, Brynmor Lloyd-Evans, Kee Lee Chou

PMC · DOI: 10.3389/fpubh.2026.1741422 · Frontiers in Public Health · 2026-02-23

## TL;DR

This study tests a multi-level program to reduce loneliness in Hong Kong's older adults living in poverty, aiming to improve well-being through individual, interpersonal, and community interventions.

## Contribution

This is the first global study to implement a multi-level intervention targeting loneliness and poverty in older adults.

## Key findings

- The study will evaluate the effectiveness of individual, interpersonal, and community-level interventions on reducing loneliness.
- Qualitative insights will explore participants' experiences with the interventions.
- The trial will assess cost-effectiveness and long-term outcomes over a 24-month follow-up period.

## Abstract

Loneliness is a widespread global issue among older adults that negatively impacts physical and mental health, cognitive functioning, quality of life, and longevity, while also burdening society with healthcare costs. Resulting from factors at individual, interpersonal, and community levels. Multi-level interventions targeting these levels show promise in addressing this complex issue.

This trial aims to develop, implement, and evaluate a multi-level intervention comprising individual-, interpersonal-, and community-level components to reduce loneliness and enhance well-being among older adults in Hong Kong.

This pragmatic, assessor-blinded, 4-arm cluster randomized controlled trial will evaluate a multi-level intervention among 1,344 community-dwelling lonely older adults living in poverty. Participants will be randomized equally to one of the four 6-month intervention groups delivered by trained volunteers: individual-level only, individual- + interpersonal-level, and individual- + interpersonal- + community-level interventions against an education-only control group. Data will be collected at six time points: baseline; 2, 4, and 6 months post baseline; and 12 and 24 months after intervention completion. Primary outcome is assessed by the Revised UCLA Loneliness Scale. Secondary outcomes include De Jong Gierveld Loneliness Scale, symptoms of anxiety and depression, perceived stress, life satisfaction, psychological well-being and sleep quality. Potential mediators will be assessed by mindfulness, self-compassion, emotion regulation, perceived social support, social network characteristics, and neighbourhood collective efficacy and identification. Analyses will follow the intention-to-treat principle, employing linear mixed-effects models, regression, mediation, and cost-effectiveness. Qualitative data collected via focus group discussions will be analysed thematically to gain deeper insight into participants’ experiences and perceptions of the different interventions.

This study will last for 4 years, starting from June 2025 to May 2029. Recruitment and enrolment will begin in March 2026. Data collection will commence in April 2026, followed by the start of intervention delivery.

To our knowledge, this is the first study globally to implement a multi-level intervention targeting older adults experiencing loneliness and poverty. If proven effective, the multi-level intervention will establish a foundation for community-wide implementation, providing a timely, affordable, and scalable approach that leverages community social capital.

ClinicalTrials.gov, identifier NCT07123064.

## Full-text entities

- **Diseases:** heart failure (MESH:D006333), depression (MESH:D003866), Social (OMIM:300082), CHN (MESH:C535301), lymphoma (MESH:D008223), dementia (MESH:D003704), fatigue (MESH:D005221), learning disability (MESH:D007859), chronic pulmonary disease (MESH:D002908), cognitive deficits (MESH:D003072), daytime dysfunction (MESH:D006970), Comorbidity (MESH:D004194), pain (MESH:D010146), sleep disturbance (MESH:D012893), COVID-19 (MESH:D000086382), diabetes (MESH:D003920), psychiatric disorder (MESH:D001523), breathlessness (MESH:D004417), Anxiety and Depression (MESH:D001007)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** T4, G4H

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12968008/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12968008/full.md

## References

96 references — full list in the complete paper: https://tomesphere.com/paper/PMC12968008/full.md

---
Source: https://tomesphere.com/paper/PMC12968008